Differences

This shows you the differences between two versions of the page.

--- home:diseases:celiac [02.19.2019] – [recent research] sallieq
+++ home:diseases:celiac [03.13.2019] – [recent research] sallieq
@@ Line 63: / Line 63: @@
 [[http://science.sciencemag.org/content/356/6333/44| study in humans supports a role for infection with reovirus, a seemingly innocuous virus, in triggering the development of CeD]]
 (({{pubmed>long:28386004}})) (({{pubmed>long:26060107}}))
+Findings suggest that neither olmesartan nor other ARBs were associated with diarrhea among patients undergoing endoscopy. The spruelike enteropathy recently associated with olmesartan is likely a rare adverse effect and milder presentations are unlikely.  (({{pubmed>long:25023670}}))
+In a methotrexate-induced model of intestinal mucositis, olmesartan reduced inflammation and induced enteropathy characterized by severe diarrhea, weight loss, and reduced sucrose activity.   (({{pubmed>long:25947920}}))
 {{tag>diseases }}

home/diseases/celiac.txt · Last modified: 09.14.2022 by 127.0.0.1